Antoninus Soosaipillai
Mount Sinai Hospital
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Comparative proteomic analysis of cerebrospinal fluid and brain tissue using Orbitrap Astral and timsTOF Pro 2 platforms with data-independent acquisition.
Journal: Diagnosis (Berlin, Germany)
Published: December 17, 2025
Validation of human kallikrein 6 in the cerebrospinal fluid of patients with progressive and non-progressive alzheimer's disease: correlation with other biomarkers.
Journal: Clinical proteomics
Published: September 26, 2025
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Journal: British journal of cancer
Published: March 04, 2023
Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes.
Journal: Clinical chemistry and laboratory medicine
Published: May 20, 2022
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study.
Journal: Clinical chemistry and laboratory medicine
Published: May 16, 2022
Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.
Journal: Biomolecules
Published: May 12, 2022
Sensitive Serology Measurements in the Saliva of Individuals with COVID-19 Symptoms Using a Multiplexed Immunoassay.
Journal: The journal of applied laboratory medicine
Published: April 25, 2022
Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.
Journal: Clinical chemistry and laboratory medicine
Published: March 14, 2022
Electronic field effect detection of SARS-CoV-2 N-protein before the onset of symptoms.
Journal: Biosensors & bioelectronics
Published: December 21, 2021
Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection.
Journal: Clinical chemistry and laboratory medicine
Published: October 26, 2021
Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line.
Journal: Clinical proteomics
Published: October 23, 2021
Last Updated: 09/26/2026